Tourmaline Bio, Inc. (TRML)
(Delayed Data from NSDQ)
$47.64 USD
+17.46 (57.85%)
Updated Sep 9, 2025 04:00 PM ET
After-Market: $47.63 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Tourmaline Bio, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
TRML 47.64 +17.46(57.85%)
Will TRML be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TRML based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TRML
Wall Street Analysts Predict a 151% Upside in Tourmaline Bio, Inc. (TRML): Here's What You Should Know
TRML: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TRML
Dow Surges Over 100 Points; Korn Ferry Earnings Top Views
12 Health Care Stocks Moving In Tuesday's Intraday Session
Nebius enters AI pact with Microsoft, Teck to combine with Anglo: Morning Buzz
Nebius enters AI pact with Microsoft, Teck to combine with Anglo: Morning Buzz
Tourmaline Bio downgraded to Market Perform from Outperform at LifeSci Capital